đŹ Current Disease Focus:
Task Progress: 0%
đĽ Active Problem Solvers
0
đ Experts collaborating globally
⥠Current Task Assignment
𧏠Genetic Analysis
đ Matching experts to specific tasks
đ Resource Allocation by Research Phase:
đ Data Analysis
𧪠Experimental Design
đŹ Clinical Trials
đ Treatment Development
The purpose of this study is to determine at 5 years of age the persistence...
Status
Completed
Location
GSK Investigational Site
Start Date
2006-12
Trial ID
NCT00411697
Treatments Being Tested
The purpose of this study is to assess the long-term persistence of immunit...
Status
Completed
Location
GSK Investigational Site
Start Date
2016-08-23
Trial ID
NCT02798952
Treatments Being Tested
This phase IV open study will evaluate the persistence of humoral antibodie...
Status
Completed
Location
GSK Investigational Site
Start Date
2009-10-12
Trial ID
NCT00984139
Treatments Being Tested
The purpose of the study is to provide data on the safety and immunogenicit...
Status
Completed
Location
Multiple Locations
Start Date
2006-09
Trial ID
NCT00355654
Treatments Being Tested
The purpose of this study is to assess the persistence of immunity to hepat...
Status
Completed
Location
GSK Investigational Site
Start Date
2007-08-31
Trial ID
NCT00519649
Treatments Being Tested
The purpose of this study is to assess the long-term persistence of immunit...
Status
Completed
Location
GSK Investigational Site
Start Date
2013-07-19
Trial ID
NCT01847430
Treatments Being Tested
The purpose of this study is to assess the long-term persistence of immunit...
Status
Completed
Location
GSK Investigational Site
Start Date
2014-02-18
Trial ID
NCT02052661
Treatments Being Tested
This study will evaluate the persistence of immunity to hepatitis B in heal...
Status
Completed
Location
GSK Investigational Site
Start Date
2011-04-26
Trial ID
NCT01333813
Treatments Being Tested